| Literature DB >> 34235095 |
Changrui Qian1,2,3, Hongmao Liu1,2,3, Jiawei Cao2, Yongan Ji2,3, Wei Lu2,3, Junwan Lu2,3, Aifang Li4, Xinyi Zhu1,2,3, Kai Shen2,3, Haili Xu1, Qianqian Chen2,3, Wangxiao Zhou2,3, Hongyun Lu5, Hailong Lin1,2,3, Xueya Zhang1,2,3, Qiaoling Li1,2,3, Xi Lin2,3, Kewei Li2,3, Teng Xu6,7, Mei Zhu8, Qiyu Bao1,2,3, Hailin Zhang1,3.
Abstract
Florfenicol is widely used to control respiratory diseases and intestinal infections in food animals. However, there are increasing reports about florfenicol resistance of various clinical pathogens. floR is a key resistance gene that mediates resistance to florfenicol and could spread among different bacteria. Here, we investigated the prevalence of floR in 430 Pseudomonas aeruginosa isolates from human clinical samples and identified three types of floR genes (designated floR, floR-T1 and floR-T2) in these isolates, with floR-T1 the most prevalent (5.3%, 23/430). FloR-T2 was a novel floR variant identified in this study, and exhibited less identity with other FloR proteins than FloRv. Moreover, floR-T1 and floR-T2 identified in P. aeruginosa strain TL1285 were functionally active and located on multi-drug resistance region of a novel incomplete Tn4371-like integrative and conjugative elements (ICE) in the chromosome. The expression of the two floR variants could be induced by florfenicol or chloramphenicol. These results indicated that the two floR variants played an essential role in the host's resistance to amphenicol and the spreading of these floR variants might be related with the Tn4371 family ICE.Entities:
Keywords: Pseudomonas aeruginosa; Tn4371; floR; florfenicol resistance; integrative and conjugative elements
Year: 2021 PMID: 34235095 PMCID: PMC8256890 DOI: 10.3389/fcimb.2021.685068
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
PCR primers used in this study.
| Primers | Purposes | Sequences | Product size (bp) |
|---|---|---|---|
| s- | screening of | GCGCAACGGCTTTCGTCATT | 270 |
| s- | GCATCGCCAGTATAGCCAAA | ||
| s- | screening of | GCGCAACGGCTTTCGTTGCT | 262 |
| s- | GCGAAGCCAGTGCAGCCAGT | ||
| s- | screening of | GGGCCATACTTTTCATCGTC | 278 |
| s- | TCAACGCCAGCACAGCAAGC | ||
| c-floR-T1-F | cloning of | GGGATTCGGTGAGAAATGGCTACG | 1600 |
| c- | AATGAGCGGTATCTTGCCAGACAG | ||
| c- | cloning of | AATCCCATGAGTTCACCCTCGTTCC | 1500 |
| c- | AATGAGCGGTATTCTGCCGGACAG | ||
| q- |
| GCGACGTATATGCCAATCGT | 184 |
| q- | CTGAAACTGGCGTTTAAGAG | ||
| q- |
| ATCTTCGCGAGTCCAGCCTT | 200 |
| q- | TCTGGCGACAAAGGACTTCG | ||
| PA16S -F |
| AACGCGAAGAACCTTACC | 149 |
| PA16S-R | AAGGGTTGCGCTCGTTAC | ||
| EC16S-F |
| AATGCCACGGTGAATACG | 153 |
| EC16S-R | CTACGGTTACCTTGTTACGA | ||
| Tn | circular forms and insertion sites of Tn | CGAGAGCGTCAAGCTGACCT | |
| Tn | GAGCGTGGGACAGCTGCTT | ||
| Tn | CAAGGATCGGGCCTTGATGT |
Figure 1MIC results of the 430 clinical P. aeruginosa isolates against florfenicol and chloramphenicol.
The abundance and PCR positive rates of the floR variants.
|
| Identity | Match length (aa) | Abundance | PCR positive rate | |
|---|---|---|---|---|---|
| TL0809 |
| 99.3% | 404 | 0.68 | 2/200 (1.00%) |
|
| 91.3% | 404 | 1.18 | 6/200 (3.00%) | |
|
| 87.6% | 404 | 0.32 | 1/200 (0.50%) | |
| TL151617 |
| 99.3% | 404 | 0.56 | 3/230 (1.30%) |
|
| 91.3% | 404 | 4.95 | 17/230 (7.39%) |
reference floR (AF231986).
MIC results of P. aeruginosa TL1285 and recombinants to 17 antibiotics (μg/mL).
| Antibiotics | TL1285 | DH5α | DH5α/pUCP24- | DH5α/pUCP24- | ΔPAO1 | ΔPAO1/pUCP24- | ΔPAO1/pUCP24-floR-T2 |
|---|---|---|---|---|---|---|---|
| Ampicillin | 1024 | – | – | – | – | – | – |
| Ceftazidime | <1 | – | – | – | – | – | – |
| Levofloxacin | <0.5 | – | – | – | – | – | – |
| Cefpyridine | 4 | – | – | – | – | – | |
| Minocycline | 64 | – | – | – | – | – | |
| Chloramphenicol | 128 | 4 | 64 | 64 | 32 | 128 | 512 |
| Florfenicol | 256 | 4 | 64 | 128 | 32 | 256 | >1024 |
| Ciprofloxacin | 2 | – | – | – | – | – | |
| Azithromycin | 32 | – | – | – | – | – | |
| Fosfomycin | 256 | – | – | – | – | – | |
| Tigecycline | 4 | – | – | – | – | – | |
| Colistin | <1 | – | – | – | – | – | – |
| Erythromycin | 256 | – | – | – | – | – | – |
| Nalidixic acid | >1024 | – | – | – | – | – | – |
| Gentamicin | >1024 | – | – | – | – | – | |
| Kanamycin | 64 | – | – | – | – | – | |
| Streptomycin | >1024 | – | – | – | – | – | – |
Figure 2Expression of the floR variants in TL1285 and corresponding transformants with or without florfenicol or chloramphenicol induction. **** (P-value < 0.0001).
Figure 3Comparison of sequences upstream of the floR variants. (A) The stable mRNA secondary structure of the floR variants formed by inverted repeat sequences boxed in (B). (B) The attenuator of the floR variants consists of a peptide-encoding region (underlined) and stem-loop region (boxed). The start codons and ribosome binding sites (RBS) of the short peptide and floR are labeled and displayed in bold type letters.
Figure 4Sequence conservation among P. aeruginosa TL1285 and 6 other genomes carrying floR-T2. From innermost to outermost: Circle 1 shows the scale in kb; Circles 2 and 3 represent the GC content and GC skew maps of TL1285, respectively; Circle 4 represents the genome of TL1285; Circles 5-10 represent the homologous regions of PASGNDM345, PASGNDM699, WPB099, WPB100, WPB101 and AR_038 compared to those of TL1285, while the regions without similar hits between them were left blank; Circle 11 displays the genomic islands in TL1285; Circle 12 displays the antibiotic resistance genes in TL1285.
Figure 5Comparative genomic analysis of the ICE region of TL1285 and 5 other floR-T2-carrying P. aeruginosa isolates. Genes with different functions are shown in different colors: red, transposable elements; yellow, drug resistance; orange, conjugational transfer; blue, plasmid maintenance; purple, replication; brown, genes with other functions; white, hypothetical proteins.